Benefit of B7-1 staining and abatacept for treatment-resistant post-transplant focal segmental glomerulosclerosis in a predominantly pediatric cohort: time for a reappraisal.
Burke GW 3rd, Chandar J, Sageshima J, Ortigosa-Goggins M, Amarapurkar P, Mitrofanova A, Defreitas MJ, Katsoufis CP, Seeherunvong W, Centeno A, Pagan J, Mendez-Castaner LA, Mattiazzi AD, Kupin WL, Guerra G, Chen LJ, Morsi M, Figueiro JMG, Vianna R, Abitbol CL, Roth D, Fornoni A, Ruiz P, Ciancio G, Garin EH.
Burke GW 3rd, et al. Among authors: seeherunvong w.
Pediatr Nephrol. 2023 Jan;38(1):145-159. doi: 10.1007/s00467-022-05549-7. Epub 2022 May 4.
Pediatr Nephrol. 2023.
PMID: 35507150
Free PMC article.